Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
1.140
-0.020 (-1.72%)
At close: Mar 31, 2025, 4:00 PM
1.165
+0.025 (2.21%)
After-hours: Mar 31, 2025, 6:17 PM EDT
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $4.95 million as of March 31, 2025. Its market cap has increased by 146.55% in one year.
Market Cap
4.95M
Enterprise Value
-1.74M
1-Year Change
146.55%
Ranking
Category
Stock Price
$1.14
Market Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $207.01M to $4.95M, a decrease of -97.61%. That is a compound annual growth rate of -75.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 5.04M | -48.44% |
| Dec 31, 2024 | 9.77M | 269.37% |
| Dec 29, 2023 | 2.64M | -71.76% |
| Dec 30, 2022 | 9.36M | -95.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |